Latest News - IQVIA
Top Corporates Hub
IQVIA
Is IQVIA's (IQV) Biotech Collaboration Signaling a New Phase in Its Long-Term Competitive Strategy?
30.08.2025 10:12
Flagship Pioneering recently announced a collaboration with IQVIA aimed at accelerating the development of breakthrough life sciences companies by leveraging IQVIA's information assets, analytics, and domain expertise across drug discovery, development, and commercialization. This partnership uniquely positions IQVIA as a core technology and analytics provider within an influential biopharma ecosystem, broadening its reach in early-stage drug innovation and commercialization support. We'll...
IQVIA Holdings (NYSE:IQV) investors are sitting on a loss of 24% if they invested a year ago
22.08.2025 12:00
It is a pleasure to report that the IQVIA Holdings Inc. ( NYSE:IQV ) is up 35% in the last quarter. But that doesn't...
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
18.08.2025 13:00
IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Under the terms of the long-term agreement, customers can use software, data, technology, and service offerings from Veeva and IQVIA together in a simple and efficient way.
UMAC Gears Up to Report Q2 Earnings: What's in the Offing?
13.08.2025 14:57
Unusual Machines prepares for second-quarter 2025 results, with revenues projected to soar more than 50% y/y on strong U.S. drone market tailwinds.
1 Cash-Producing Stock for Long-Term Investors and 2 We Question
13.08.2025 04:35
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
IQVIA Holdings (IQV) Enters Partnership With Kexing Biopharm To Enhance Drug Development
12.08.2025 17:53
IQVIA Holdings (IQV) recently forged a strategic partnership with Kexing Biopharm, aiming to bolster the clinical development and market integration of innovative therapeutics globally. Over the last quarter, IQVIA's stock price rose by 19.52%, aligning closely with broader market trends. This partnership has likely contributed positively by highlighting the company's commitment to international expansion. Concurrently, the broader market optimism driven by expectations of potential Federal...
Ave Maria Growth Fund Q2 2025 Commentary
08.08.2025 05:45
The Fundâs goal is to purchase shares of exceptional companies at attractive prices with the expectation of earning favorable returns over the long run. Read more here.
What Is IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Doing?
06.08.2025 11:00
Today we're going to take a look at the well-established IQVIA Holdings Inc. ( NYSE:IQV ). The company's stock saw a...
IQVIA Holdings Inc (IQV) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic AI ...
23.07.2025 07:08
IQVIA Holdings Inc (IQV) surpasses $4 billion in quarterly revenue for the first time, while leveraging AI to drive growth despite a challenging market environment.
IQV Q2 Deep Dive: AI Initiatives and Pipeline Growth Drive Outperformance Amid Margin Pressures
23.07.2025 05:32
Clinical research company IQVIA (NYSE: IQV) announced better-than-expected revenue in Q2 CY2025, with sales up 5.3% year on year to $4.02 billion. The company’s full-year revenue guidance of $16.2 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $2.81 per share was 1.4% above analysts’ consensus estimates.
IQVIA Holdings (IQV) Updates 2025 Revenue Guidance and Completes Share Buyback
22.07.2025 17:42
IQVIA Holdings (IQV) recently updated its earnings guidance for 2025 with expectations of revenue ranging between $16,100 million and $16,300 million. This update coincides with the company's Q2 earnings announcement, showing an increase in sales to $4,017 million but a decline in net income to $266 million. During the last quarter, IQVIA's share price rose 11%, likely supported by its ongoing share buyback program, where the company repurchased 3,985,000 shares. Despite the broader market...
Medpace Surges 52% On 'Shockingly Strong' Report; Pulling Iqvia Higher
22.07.2025 17:27
Medpace and Iqvia stocks surged Tuesday after the duo kicked off earnings season with unexpectedly strong reports.
IQVIA Earnings & Revenues Beat Estimates in Q2, Rise Y/Y
22.07.2025 16:15
IQV tops second-quarter 2025 estimates, with earnings up 6.4% and revenue rising 5.5%. It cuts the 2025 EBITDA guidance.
Why IQVIA (IQV) Stock Is Trading Up Today
22.07.2025 15:55
Shares of clinical research company IQVIA (NYSE: IQV) jumped 15.9% in the morning session after the company reported second-quarter financial results that beat Wall Street expectations and raised its full-year profit guidance.
Oakmark Global Concentrated Strategy Q2 2025 Commentary
22.07.2025 15:21
Oakmark Global Concentrated Strategyâs return was 5.17% (net) for the reporting period. This compares to the MSCI World Index that returned 11.47% for the same period.
IQVIA Holdings Inc. (IQV) Q2 2025 Earnings Call Transcript
22.07.2025 14:00
IQVIA Holdings Inc. (NYSE:IQV) Q2 2025 Earnings Conference Call July 22, 2025 9:00 AM ETCompany ParticipantsAri Bousbib - CEO & ChairmanKerri Joseph -...
Wall Street Set to Open Flat Tuesday; Powell Says US Banks Must Manage Key Risks
22.07.2025 13:26
US stocks look set to open flat Tuesday as investors parsed Federal Reserve Chair Jerome Powell's op
Oakmark Global All Cap Strategy Q2 2025 Commentary
22.07.2025 13:14
Oakmark Global All Cap Strategyâs return was 6.20% (Net) for the reporting period. This compares to the MSCI World Index that returned 11.47% for the same period.
Iqvia Surges As 'Pluses' Outweigh 'Minuses' In Its Second-Quarter Report
22.07.2025 13:08
Iqvia stock surged Tuesday after the clinical resource organization widely beat most second-quarter metrics, though trimmed its outlook.